AGO2, argonaute RISC catalytic component 2, 27161

N. diseases: 186; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.040 AlteredExpression group BEFREE Our results show an upregulation of AGO1, AGO2 and Drosha in non-muscle-invasive bladder carcinomas, while there was increased protein expression of only AGO2 in muscle-invasive bladder carcinomas. 29857476 2018
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.040 AlteredExpression group BEFREE There were higher EIF2C2, Dicer, and Drosha expressions in carcinomas than in the adjacent normal tissues, positive correlations being noted with clinical stage, histopathologic grade, and recurrence. 25656609 2015
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.040 AlteredExpression group BEFREE Significantly higher expression of all 4 messenger RNAs was found in effusions compared with primary carcinomas (P<.001 to P=.006), whereas Argonaute 2 messenger RNA (P=.002), Drosha messenger RNA (P=.009), and Dicer protein (P=.006) were overexpressed in solid metastases compared with primary carcinomas. 22647351 2012
CUI: C0007097
Disease: Carcinoma
Carcinoma
0.040 Biomarker group BEFREE In addition, higher expression of the miRNA-processing molecules Ago1, Ago2 and Dicer was observed in effusions compared to primary carcinomas. 20716115 2011